Evidence map›Paper›PMID 33488333›Full record

ArticlePrzeglad menopauzalny = Menopause review2020

Vaginal dehydroepiandrosterone compared to other methods of treating vaginal and vulvar atrophy associated with menopause.

Wojciech Pięta, Roman Smolarczyk

Registry-linked trialOpen access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Przeglad menopauzalny = Menopause review, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07574216 (The Use of Vaginal Estrogen vs DHEA in Perimenopausal and Menopausal Women), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07574216 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

The Use of Vaginal Estrogen vs DHEA in Perimenopausal and Menopausal Women

TypeinterventionalSponsorUniversity of ArizonaRan2026 to 2031Enrolled324ConditionsPost-menopause, Pre-menopause, Sexual Function, MenopauseArmsDHEA ovals, Estradiol 0.01% Vag Cream
3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Non-oestrogenic modalities to reverse urogenital aging.Przeglad menopauzalny = Menopause review · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Wojciech PiętaDepartment of Gynecological Endocrinology, Medical University of Warsaw, Poland.
Roman SmolarczykDepartment of Gynecological Endocrinology, Medical University of Warsaw, Poland.
Medical University of Warsaw · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During the menopause, a fall in estrogen levels often leads to many unfavorable symptoms, including changes in the vascular and urogenital systems, in mood, and sleep. The symptoms of vulvovaginal atrophy are especially troublesome for menopausal women. These symptoms not only disturb the sexual sphere, but also functioning at work and in the family. Based on the literature, a review of contemporary methods of management in the case of symptoms of vulvar atrophy in menopausal women has been performed. The current methods of treating vulvovaginal atrophy in menopausal women are described. The pharmacology of the available dehydroepiandrosterone (DHEA) preparations, both oral and vaginal, was briefly analyzed. Own experiences of using DHEA are presented. Vaginal DHEA has been found to be an effective and safe treatment in menopausal women with symptoms of vaginal atrophy.

Indexed as

DHEAmenopausevulvovaginal atrophy

Identifiers

PMID33488333
PMCPMC7812532
OpenAlexW3120386621

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.